Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

BACKGROUND: Prospectively and systematically collected real-world data on vedolizumab are scarce. We aimed to assess the long-term clinical effectiveness of vedolizumab in inflammatory bowel disease (IBD). METHODS: This study was a prospective, observational, multicentre study. Overall, 286 patients...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Therap Adv Gastroenterol
Main Authors: Eriksson, Carl, Rundquist, Sara, Lykiardopoulos, Vyron, Udumyan, Ruzan, Karlén, Per, Grip, Olof, Söderman, Charlotte, Almer, Sven, Hertervig, Erik, Marsal, Jan, Gunnarsson, Jenny, Malmgren, Carolina, Delin, Jenny, Strid, Hans, Sjöberg, Mats, Öberg, David, Bergemalm, Daniel, Hjortswang, Henrik, Halfvarson, Jonas
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2021
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255566/
https://ncbi.nlm.nih.gov/pubmed/34276808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562848211023386
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares